Patent foramen ovale screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 8: | Line 8: | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for [[patent foramen ovale]]. | *There is insufficient evidence to recommend routine screening for [[patent foramen ovale]] but screening is common in younger patients (less than 55) with a history of cryptogenic stroke. It is usually detected by echocardiography. | ||
==References== | ==References== | ||
Revision as of 16:34, 13 February 2020
|
Patent Foramen Ovale Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Patent foramen ovale screening On the Web |
|
American Roentgen Ray Society Images of Patent foramen ovale screening |
|
Risk calculators and risk factors for Patent foramen ovale screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2]
Overview
There is insufficient evidence to recommend routine screening for patent foramen ovale.
Screening
- There is insufficient evidence to recommend routine screening for patent foramen ovale but screening is common in younger patients (less than 55) with a history of cryptogenic stroke. It is usually detected by echocardiography.